Advertisement

Supportive Care in Cancer

, Volume 26, Issue 1, pp 213–222 | Cite as

Prevalence of hyponatremia in inpatients with incurable and life-limiting diseases and its association with physical symptoms—a retrospective descriptive study

  • Kerstin Kremeike
  • Ricarda M. L. Wetter
  • Volker Burst
  • Raymond Voltz
  • Kathrin Kuhr
  • Steffen T. SimonEmail author
Original Article

Abstract

Purpose

Hyponatremia is a common electrolyte abnormality seen in hospitalized patients. It may cause a variety of symptoms and is associated with longer hospitalizations and higher mortality. However, to date, only little is known about the extent of hyponatremia in patients with incurable diseases and whether it is associated with physical symptoms in this patient group. This study aims to describe the prevalence of hyponatremia, associated symptoms, and symptom intensity in inpatients with hyponatremia receiving specialist palliative care (SPC).

Methods

This is a retrospective study. Demographic and clinical data as well as symptoms, scored symptom intensity, and laboratory values were collected. All inpatients of a large German University Hospital receiving SPC in 2013 with documented sodium values were included.

Results

In 2013, 789 inpatients received SPC of which 710 had documented sodium values. The prevalence of hyponatremia was 38.7% (275/710). A mild degree showed 220 (31,0%), 44 (6.2%) had a moderate, and 11 (1.6%) a severe form. Hyponatremia patients experienced significantly more symptoms than normonatremic patients (mean = 7.71 vs 6.63; p < 0.001). Breathlessness, depressiveness, nausea, vomiting, poor appetite, constipation, and weakness were significantly more frequent in patients with hyponatremia. Furthermore, hyponatremia severity was associated with higher symptom intensity (mean = 13.29 vs 11.28; p < 0.001).

Conclusions

More than one third of all SPC patients showed a hyponatremia, and the hyponatremia grade was associated with symptom burden and symptom intensity. A prospective analysis is needed to further examine this association and the possible influence of hyponatremia correction on symptom burden reduction.

Keywords

Hyponatremia Palliative care Symptoms Prevalence 

Notes

Acknowledgements

We thank Mr. Abdelghani Bensaid, Information Technology, University Hospital Cologne, for his support to identify SPC patients and to determine length of stay and in-hospital mortality.

Compliance with Ethical Standards

It was approved by the Ethics Committee of the University Hospital Cologne (No. 15-197).

Funding

This study was funded by an unrestricted research grant from Otsuka Pharmaceutical Europe Ltd. (OPEL; manufacturer of a drug to treat hyponatremia). The funder had no influence on the study design and the collection of data and did not have any role in execution, analyses, interpretation of the data, decision to submit results, or writing the article.

Conflict of Interests

Dr. Burst is a consultant and his institution received research support from Otsuka for the Hyponatremia Registry. He received travel support and fees for data review activities, and serves on a speakers’ bureau for Otsuka.

Dr. Simon is a consultant and his institution received the unrestricted research grant from Otsuka for this study.

All other authors declare no competing interests.

References

  1. 1.
    Adrogue HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342(21):1581–1589. doi: 10.1056/nejm200005253422107 CrossRefPubMedGoogle Scholar
  2. 2.
    Upadhyay A, Jaber BL, Madias NE (2009) Epidemiology of hyponatremia. Semin Nephrol 29(3):227–238. doi: 10.1016/j.semnephrol.2009.03.004 CrossRefPubMedGoogle Scholar
  3. 3.
    Gill G, Huda B, Boyd A, Skagen K, Wile D, Watson I, van Heyningen C (2006) Characteristics and mortality of severe hyponatraemia--a hospital-based study. Clin Endocrinol 65(2):246–249. doi: 10.1111/j.1365-2265.2006.02583.x CrossRefGoogle Scholar
  4. 4.
    Castillo JJ, Vincent M, Justice E (2012) Diagnosis and management of hyponatremia in cancer patients. Oncologist 17(6):756–765. doi: 10.1634/theoncologist.2011-0400 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Greenberg A, Verbalis JG, Amin AN, Burst VR, Chiodo JA 3rd, Chiong JR, Dasta JF, Friend KE, Hauptman PJ, Peri A, Sigal SH (2015) Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int 88(1):167–177. doi: 10.1038/ki.2015.4 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Nigro N, Winzeler B, Suter-Widmer I, Schuetz P, Arici B, Bally M, Blum C, Bingisser R, Bock A, Huber A, Muller B, Nickel CH, Christ-Crain M (2015) Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study. J Am Geriatr Soc 63(3):470–475. doi: 10.1111/jgs.13325 CrossRefPubMedGoogle Scholar
  7. 7.
    Balling L, Gustafsson F, Goetze JP, Dalsgaard M, Nielsen H, Boesgaard S, Bay M, Kirk V, Nielsen OW, Kober L, Iversen K (2015) Hyponatraemia at hospital admission is a predictor of overall mortality. Intern Med J 45(2):195–202. doi: 10.1111/imj.12623 CrossRefPubMedGoogle Scholar
  8. 8.
    Sepulveda C, Marlin A, Yoshida T, Ullrich A (2002) Palliative care: the World Health Organization's global perspective. J Pain Symptom Manag 24(2):91–96CrossRefGoogle Scholar
  9. 9.
    Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manag 31(1):58–69. doi: 10.1016/j.jpainsymman.2005.06.007 CrossRefGoogle Scholar
  10. 10.
    Bausewein C, Simon ST, Pralong A, Radbruch L, Nauck F, Voltz R (2015) Palliative Care of Adult Patients with Cancer. Dtsch Arztebl Int 112(50):863–870. doi: 10.3238/arztebl.2015.0863 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Stewart AF (2005) Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 352(4):373–379. doi: 10.1056/NEJMcp042806 CrossRefPubMedGoogle Scholar
  12. 12.
    Mallik S, Mallik G, Macabulos ST, Dorigo A (2016) Malignancy associated hypercalcaemia-responsiveness to IV bisphosphonates and prognosis in a palliative population. Support Care Cancer : O J Multinatl Assoc Support Care Cancer 24(4):1771–1777. doi: 10.1007/s00520-015-2962-8 CrossRefGoogle Scholar
  13. 13.
    Simon ST, Altfelder N, Alt-Epping B, Bausewein C, Weingartner V, Voltz R, Ostgathe C, Radbruch L, Lindena G (1946) Nauck F (2016) [characteristics of patients with breathlessness - results of the german hospice and palliative care evaluation]. Dtsch Med Wochenschr 141(10):e87–e95. doi: 10.1055/s-0041-106678 CrossRefGoogle Scholar
  14. 14.
    Simon ST, Altfelder N, Alt-Epping B, Bausewein C, Weingartner V, Voltz R, Ostgathe C, Radbruch L, Lindena G, Nauck F (2014) Is breathlessness what the professional says it is? Analysis of patient and professionals' assessments from a German nationwide register. Support Care Cancer : O J Multinatl Assoc Support Care Cancer 22(7):1825–1832. doi: 10.1007/s00520-014-2131-5 CrossRefGoogle Scholar
  15. 15.
    Stiel S, Pollok A, Elsner F, Lindena G, Ostgathe C, Nauck F, Radbruch L (2012) Validation of the symptom and problem checklist of the German hospice and palliative care evaluation (HOPE). J Pain Symptom Manag 43(3):593–605. doi: 10.1016/j.jpainsymman.2011.04.021 CrossRefGoogle Scholar
  16. 16.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefGoogle Scholar
  17. 17.
    Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245–1251CrossRefGoogle Scholar
  18. 18.
  19. 19.
    Abu Zeinah GF, Al-Kindi SG, Hassan AA, Allam A (2015) Hyponatraemia in cancer: association with type of cancer and mortality. Eur J Cancer Care 24(2):224–231. doi: 10.1111/ecc.12187 CrossRefGoogle Scholar
  20. 20.
    Choi JS, Bae EH, Ma SK, Kweon SS, Kim SW (2015) Prognostic impact of hyponatraemia in patients with colorectal cancer. Colorectal Disease : J Assoc Coloproctology Great Britain Ireland 17(5):409–416. doi: 10.1111/codi.12878 CrossRefGoogle Scholar
  21. 21.
    Nair S, Mary TR, Tarey SD, Daniel SP, Austine J (2016) Prevalence of hyponatremia in palliative care patients. Indian J Palliative Care 22(1):33–37. doi: 10.4103/0973-1075.173954 CrossRefGoogle Scholar
  22. 22.
    Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec'h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Zeni F, Timsit JF (2013) Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Critical Care (London, England) 17(1):R12. doi: 10.1186/cc11937 CrossRefGoogle Scholar
  23. 23.
    Yoon J, Ahn SH, Lee YJ, Kim CM (2015) Hyponatremia as an independent prognostic factor in patients with terminal cancer. Support Care Cancer : Off J Multinatl Assoc Support Care Cancer 23(6):1735–1740. doi: 10.1007/s00520-014-2522-7 CrossRefGoogle Scholar
  24. 24.
    Moens K, Higginson IJ, Harding R (2014) Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review. J Pain Symptom Manag 48(4):660–677. doi: 10.1016/j.jpainsymman.2013.11.009 CrossRefGoogle Scholar
  25. 25.
    Arampatzis S, Frauchiger B, Fiedler GM, Leichtle AB, Buhl D, Schwarz C, Funk GC, Zimmermann H, Exadaktylos AK, Lindner G (2012) Characteristics, symptoms, and outcome of severe dysnatremias present on hospital admission. The Am J Med 125(11):1125 e1121–1125 e1127. doi: 10.1016/j.amjmed.2012.04.041 CrossRefGoogle Scholar
  26. 26.
    Balachandran K, Okines A, Gunapala R, Morganstein D, Popat S (2015) Resolution of severe hyponatraemia is associated with improved survival in patients with cancer. BMC Cancer 15:163. doi: 10.1186/s12885-015-1156-6 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Ayus JC, Achinger SG, Arieff A (2008) Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia. Am J Physiol Renal Physiol 295(3):F619–F624. doi: 10.1152/ajprenal.00502.2007 CrossRefPubMedGoogle Scholar
  28. 28.
    Berardi R, Caramanti M, Castagnani M, Guglielmi S, Marcucci F, Savini A, Morgese F, Rinaldi S, Ferrini C, Tiberi M, Torniai M, Rovinelli F, Fiordoliva I, Onofri A, Cascinu S (2015) Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. Support Care Cancer : Off J Multinatl Assoc Support Care Cancer 23(10):3095–3101. doi: 10.1007/s00520-015-2683-z CrossRefGoogle Scholar
  29. 29.
    Rondon-Berrios H, Berl T (2015) Mild chronic hyponatremia in the ambulatory setting: significance and management. Clinical J Am Soc Nephrol : CJASN 10(12):2268–2278. doi: 10.2215/cjn.00170115 CrossRefGoogle Scholar
  30. 30.
    Elsayem A, Mori M, Parsons HA, Munsell MF, Hui D, Delgado-Guay MO, Paraskevopoulos T, Fadul NA, Bruera E (2010) Predictors of inpatient mortality in an acute palliative care unit at a comprehensive cancer center. Support Care Cancer : Off J Multinatl Assoc Support Care Cancer 18(1):67–76. doi: 10.1007/s00520-009-0631-5 CrossRefGoogle Scholar
  31. 31.
    Matsunuma R, Tanbo Y, Asai N, Ohkuni Y, Watanabe S, Murakami S, Kawaura Y, Kasahara K (2014) Prognostic factors in patients with terminal stage lung cancer. J Palliat Med 17(2):189–194. doi: 10.1089/jpm.2013.0448 CrossRefPubMedGoogle Scholar
  32. 32.
    Vincent F, Ayed S, Bouguerba A, Goldgran-Toledano D, Bornstain C (2016) Hyponatremia in solid-tumor cancer patients: uncertainty regarding the use of vaptans. Support Care Cancer : Off J Multinatl Assoc Support Care Cancer 24(9):3685–3686. doi: 10.1007/s00520-016-3178-2 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Kerstin Kremeike
    • 1
    • 2
  • Ricarda M. L. Wetter
    • 1
    • 2
  • Volker Burst
    • 3
  • Raymond Voltz
    • 1
    • 2
    • 4
    • 5
  • Kathrin Kuhr
    • 6
  • Steffen T. Simon
    • 1
    • 2
    • 4
    Email author
  1. 1.Department of Palliative MedicineUniversity Hospital CologneCologneGermany
  2. 2.Centre for Integrated Oncology Köln Bonn (CIO)University Hospital CologneCologneGermany
  3. 3.Department 2 of Internal Medicine, NephrologyUniversity Hospital CologneCologneGermany
  4. 4.Clinical Trials Center Cologne, (ZKS)KölnGermany
  5. 5.Center for Health Services Research (ZVFK), Medical FacultyUniversity of CologneCologneGermany
  6. 6.Institute of Medical Statistics, Informatics and Epidemiology (IMSIE)University Hospital CologneCologneGermany

Personalised recommendations